Leuprolide and anorexia Patient Reports February 12, 2012
Leuprolide Side Effects Report #5981332-2
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 27, 2008. Male patient, 81 years of age, was diagnosed with prostate cancer stage iv, anorexia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, prostate cancer
. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, FLUTAMIDE, ESTRAMUSTINE PHOSPHATE, DEXAMETHASONE. Patient died on 08/04/2008.Leuprolide Side Effects Report #5395634-4
Leuprolide side effect was reported by a Physician from JAPAN on July 17, 2007. Male patient, 79 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, cardiac failure congestive, cardiomegaly, condition aggravated, dyspnoea, haemodialysis, heart rate irregular, oedema, oxygen saturation decreased. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with CASODEC, ARTIST, ALDACTONE, ACECOL, OMEPRAL, LOSARTAN POTASSIUM, FERROMIA, PURSENNID. Patient recovered.
Leuprolide Side Effects Report #5451818-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Sept 07, 2007. Male patient, 79 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, arrhythmia
, cardiac failure congestive, haemodialysis, pleural effusion, renal failure acute, respiratory tract infection. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, ARTIST, ALDACTONE, ACECOL, OMEPRAL, NU LOTAN, FERROMIA, PURSENNID. Patient recovered.Leuprolide Side Effects Report #5760191-7
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on May 26, 2008. Male patient, 73 years of age, was diagnosed with prostate cancer stage iv, metastases to bone and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, depression
, metastases to bone, prostate cancer stage iv. Leuprolide dosage: unknown. During the same period patient was treated with MORPHINE ELIXIR, BICALUTAMIDE, CHLORMADINONE ACETATE, ESTRAMUSTINE PHOSPHATE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, ZOLEDRONIC ACID, OXYCODONE HYDROCHLORIDE. Patient died on 11/17/2007.Leuprolide Side Effects Report #5817940-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on July 16, 2008. Male patient, 80 years of age, was diagnosed with prostate cancer stage ii, reflux oesophagitis, benign prostatic hyperplasia, gastritis and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: adenosquamous cell lung cancer, anorexia, back pain
, chest pain
, nausea
. Leuprolide dosage: unknown. During the same period patient was treated with LANSOPRAZOLE, BICALUTAMIDE, TAMSULOSIN, REBAMIPIDE, MOSAPRIDE CITRATE, MARZULENE S. Patient was hospitalized. Patient died on 04/26/2008.Leuprolide Side Effects Report #5764398-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 03, 2008. Male patient, 76 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, disseminated intravascular coagulation, pancreatic carcinoma. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE. Patient was hospitalized. Patient died on 02/09/2007.
Leuprolide Side Effects Report #5865899-0
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Aug 20, 2008. Male patient, 76 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, disseminated intravascular coagulation, pancreatic carcinoma. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE. Patient was hospitalized. Patient died on 02/09/2007.
Leuprolide Side Effects Report #4875734-5
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2005. Male patient, 73 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, condition aggravated, dyspepsia, gamma-glutamyltransferase increased, jaundice
. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4895456-4
Leuprolide side effect was reported by a Health Professional from JAPAN on Jan 23, 2006. Male patient, 73 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, dyspepsia, gamma-glutamyltransferase increased, jaundice
, liver disorder. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D), SUBCUTANEOUS. During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4635674-3
Leuprolide side effect was reported by a Consumer or non-health professional from on Apr 06, 2005. Male patient, 71 years of age, was diagnosed with prostate cancer stage ii, gastric ulcer, helicobacter infection and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, carcinoembryonic antigen increased, gastric ulcer, hepatic atrophy, hepatic failure, hepatic neoplasm, hepatic steatosis, hot flush. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with LANSOPRAZOLE, LEUPROLIDE ACETATE, CLARITHROMYCIN, AMOXICILLIN, GASTROM. Patient was hospitalized. Patient recovered.
Leuprolide Side Effects Report #5821708-7
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on July 09, 2008. Male patient, 97 years of age, was diagnosed with prostate cancer
, benign prostatic hyperplasia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: altered state of consciousness, anorexia, cerebral infarction, convulsion, eye movement disorder, pneumonia mycoplasmal, urinary tract infection
, wheezing. Leuprolide dosage: unknown. During the same period patient was treated with FLUTAMIDE, TAMSULOSIN, AMBROXOL HYDROCHLORIDE, TULOBUTEROL HYDROCHLORIDE, BETAMETHASONE. Patient was hospitalized. Patient died on 02/07/2008.Leuprolide Side Effects Report #4772441-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Sept 02, 2005. Male patient, 92 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, aortic aneurysm
, benign prostatic hyperplasia, calcinosis, condition aggravated, cyanosis, difficulty in walking, disseminated intravascular coagulation, fall
. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. Patient recovered.Leuprolide Side Effects Report #5141130-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Oct 20, 2006. Male patient, 86 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, brain stem ischaemia, facial palsy, faeces discoloured, haemorrhage subcutaneous, hypoaesthesia, idiopathic thrombocytopenic purpura, marrow hyperplasia, myelodysplastic syndrome. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with HARNAL D. Patient recovered.Leuprolide Side Effects Report #4820863-5
Leuprolide side effect was reported by a Consumer or non-health professional from AUSTRIA on Nov 01, 2005. Male patient, 85 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, depression
, fatigue, hyperhidrosis, retinal injury, retinal vascular thrombosis, sleep disorder
, visual acuity reduced. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 3M). Patient recovered.Leuprolide Side Effects Report #5966788-3
Leuprolide side effect was reported by a Health Professional from JAPAN on Nov 19, 2008. Male patient, 80 years of age, was diagnosed with prostate cancer
, urinary incontinence
, neurogenic bladder, osteoporosis
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, c-reactive protein increased, dehydration, platelet count decreased, pyelonephritis, pyrexia. Leuprolide dosage: unknown. During the same period patient was treated with DECADRON, PROPIVERINE HYDROCHLORIDE, PROPIVERINE HYDROCHLORIDE, ASPARTATE CALCIUM, CALCITRIOL. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5640450-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Feb 20, 2008. Male patient, 79 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, computerised tomogram abnormal, cough, dyspnoea, interstitial lung disease, malaise, pneumocystis jiroveci pneumonia, productive cough, pseudomonas infection. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, PIROAN, BUFFERIN, NEUQUINON, ACTOSIN, TANATRIL, VASTAREL F, LOXONIN. Patient was hospitalized. Patient died.Leuprolide Side Effects Report #5700964-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Apr 01, 2008. Male patient, 79 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, interstitial lung disease, klebsiella infection, pneumocystis jiroveci pneumonia, pseudomonas infection, respiratory failure. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, PIROAN, BUFFERIN, NEUQUINON, ACTOSIN, TANATRIL, VASTAREL F, LOXONIN. Patient was hospitalized. Patient died.Leuprolide Side Effects Report #4801104-1
Leuprolide side effect was reported by a Physician from JAPAN on Oct 07, 2005. Male patient, 78 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, blood ph decreased, dehydration, hyperhidrosis, myalgia, renal failure acute, sweat gland disorder. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with PRAVASTATIN, KREMEZIN, ALLOPURINOL. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5151883-1
Leuprolide side effect was reported by a Physician from JAPAN on Nov 07, 2006. Male patient, 76 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, dyspepsia, hepatomegaly, jaundice
, ocular icterus. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE, BEZATOL, DORAL, EVAMYL. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5362673-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2007. Female patient, 45 years of age, was diagnosed with endometriosis
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: abdominal pain lower, acute abdomen, anorexia, ascites, genital haemorrhage, intestinal obstruction, intestinal perforation, intestinal stenosis, nausea
. Leuprolide dosage: 1.88 MG (1.88 MG, 1 IN 28 D), SUBCUTANEOUS. During the same period patient was treated with LEUPROLIDE ACETATE. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4914140-1
Leuprolide side effect was reported by a Physician from JAPAN on Feb 09, 2006. Female patient, 45 years of age, was diagnosed with endometriosis
, gastrointestinal disorder and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: acute abdomen, anorexia, ascites, deep vein thrombosis
, genital haemorrhage, ileal perforation, intestinal obstruction, intestinal stenosis, liver abscess. Leuprolide dosage: 1.88 MG (1.88 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE. Patient was hospitalized. Patient recovered.
Leuprolide and anorexia 